Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum von Hardy, Timothy, Oakley, Fiona, Anstee, Quentin M, Day, Christopher P

Volltext

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management von McPherson, Stuart, Hardy, Tim, Henderson, Elsbeth, Burt, Alastair D, Day, Christopher P, Anstee, Quentin M

Volltext

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review von Thoma, Christian, Day, Christopher P, Trenell, Michael I

Volltext

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 von Estes, Chris, Anstee, Quentin M., Arias-Loste, Maria Teresa, Bantel, Heike, Bellentani, Stefano, Caballeria, Joan, Colombo, Massimo, Craxi, Antonio, Crespo, Javier, Day, Christopher P., Eguchi, Yuichiro, Geier, Andreas, Kondili, Loreta A., Kroy, Daniela C., Lazarus, Jeffrey V., Loomba, Rohit, Manns, Michael P., Marchesini, Giulio, Nakajima, Atsushi, Negro, Francesco, Petta, Salvatore, Ratziu, Vlad, Romero-Gomez, Manuel, Sanyal, Arun, Schattenberg, Jörn M., Tacke, Frank, Tanaka, Junko, Trautwein, Christian, Wei, Lai, Zeuzem, Stefan, Razavi, Homie

Volltext

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease von Hardy, Timothy, Zeybel, Mujdat, Day, Christopher P, Dipper, Christian, Masson, Steven, McPherson, Stuart, Henderson, Elsbeth, Tiniakos, Dina, White, Steve, French, Jeremy, Mann, Derek A, Anstee, Quentin M, Mann, Jelena

Volltext

Gut Microbiota and Lifestyle Interventions in NAFLD von Houghton, David, Stewart, Christopher J, Day, Christopher P, Trenell, Michael

Volltext

Prednisolone or Pentoxifylline for Alcoholic Hepatitis von Thursz, Mark R, Richardson, Paul, Allison, Michael, Austin, Andrew, Bowers, Megan, Day, Christopher P, Downs, Nichola, Gleeson, Dermot, MacGilchrist, Alastair, Grant, Allister, Hood, Steven, Masson, Steven, McCune, Anne, Mellor, Jane, O’Grady, John, Patch, David, Ratcliffe, Ian, Roderick, Paul, Stanton, Louise, Vergis, Nikhil, Wright, Mark, Ryder, Stephen, Forrest, Ewan H

Volltext

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers von Guha, Indra Neil, Parkes, Julie, Roderick, Paul, Chattopadhyay, Dipanker, Cross, Richard, Harris, Scott, Kaye, Philip, Burt, Alastair D., Ryder, Steve D., Aithal, Guruprasad P., Day, Christopher P., Rosenberg, William M.

Volltext

Standardization of nomenclature and causality assessment in drug‐induced liver injury: Summary of a clinical research workshop von Fontana, Robert J., Seeff, Leonard B., Andrade, Raúl J., Björnsson, Einar, Day, Christopher P., Serrano, Jose, Hoofnagle, Jay H.

Volltext

Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis von Weston, Chris J, Shepherd, Emma L, Claridge, Lee C, Rantakari, Pia, Curbishley, Stuart M, Tomlinson, Jeremy W, Hubscher, Stefan G, Reynolds, Gary M, Aalto, Kristiina, Anstee, Quentin M, Jalkanen, Sirpa, Salmi, Marko, Smith, David J, Day, Christopher P, Adams, David H

Volltext

Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles von Lucena, M. Isabel, Molokhia, Mariam, Shen, Yufeng, Urban, Thomas J, Aithal, Guruprasad P, Andrade, Raúl J, Day, Christopher P, Ruiz–Cabello, Francisco, Donaldson, Peter T, Stephens, Camilla, Pirmohamed, Munir, Romero–Gomez, Manuel, Navarro, Jose Maria, Fontana, Robert J, Miller, Michael, Groome, Max, Bondon–Guitton, Emmanuelle, Conforti, Anita, Stricker, Bruno H.C, Carvajal, Alfonso, Ibanez, Luisa, Yue, Qun–Ying, Eichelbaum, Michel, Floratos, Aris, Pe'er, Itsik, Daly, Mark J, Goldstein, David B, Dillon, John F, Nelson, Matthew R, Watkins, Paul B, Daly, Ann K

Volltext

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease von Targher, Giovanni, Day, Christopher P, Bonora, Enzo

Volltext

Non-alcoholic fatty liver disease: a massive problem von Thomas, Howard C, Day, Christopher P

Volltext

Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury von Donaldson, Peter T, Daly, Ann K, Henderson, Jill, Graham, Julia, Pirmohamed, Munir, Bernal, William, Day, Christopher P, Aithal, Guruprasad P

Volltext

The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies von Al-Serri, Ahmad, Anstee, Quentin M, Valenti, Luca, Nobili, Valerio, Leathart, Julian B.S, Dongiovanni, Paola, Patch, Julia, Fracanzani, Anna, Fargion, Silvia, Day, Christopher P, Daly, Ann K

Volltext

A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis von McPherson, Stuart, Wilkinson, Nina, Tiniakos, Dina, Wilkinson, Jennifer, Burt, Alastair D, McColl, Elaine, Stocken, Deborah D, Steen, Nick, Barnes, Jane, Goudie, Nicola, Stewart, Stephen, Bury, Yvonne, Mann, Derek, Anstee, Quentin M, Day, Christopher P

Volltext

NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men von Targher, Giovanni, Bertolini, Lorenzo, Rodella, Stefano, Lippi, Giuseppe, Franchini, Massimo, Zoppini, Giacomo, Muggeo, Michele, Day, Christopher P.

Volltext

Genetic Susceptibility to Diclofenac-Induced Hepatotoxicity: Contribution of UGT2B7, CYP2C8, and ABCC2 Genotypes von Daly, Ann K, Aithal, Guruprasad P, Leathart, Julian B.S, Swainsbury, Richard A, Dang, Tarana Singh, Day, Christopher P

Volltext

Pathogenesis of alcohol-induced liver disease: Classical concepts and recent advances von Seth, Devanshi, Haber, Paul S, Syn, Wing-Kin, Diehl, Anna Mae, Day, Christopher P

Volltext

Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease von Anstee, Quentin M, Seth, Devanshi, Day, Christopher P

Volltext